CONMED Corporation P/E Ratio 2009–2025
CONMED Corporation reported 26.89 of price-to-earnings ratio for fiscal 2025. That was 69.3% higher than fiscal 2024. Compared with fiscal 2020, the change was -92.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 26.89 | +69.3% |
| FY 2024 | 15.88 | -69.7% |
| FY 2023 | 52.45 | — |
| FY 2022 | — | — |
| FY 2021 | 70.34 | -79.0% |
| FY 2020 | 334.71 | +206.6% |
| FY 2019 | 109.17 | +155.7% |
| FY 2018 | 42.69 | +78.2% |
| FY 2017 | 23.96 | -69.0% |
| FY 2016 | 77.33 | +114.3% |
| FY 2015 | 36.09 | +6.0% |
| FY 2014 | 34.06 | +19.0% |
| FY 2013 | 28.63 | +70.8% |
| FY 2012 | 16.76 | -97.6% |
| FY 2011 | 711.98 | +3299.4% |
| FY 2010 | 20.94 | -53.6% |
| FY 2009 | 45.17 | — |
Source: CONMED Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CNMD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
CONMED Corporation reported 26.89 of price-to-earnings ratio for fiscal 2025. That was 69.3% higher than fiscal 2024. Compared with fiscal 2020, the change was -92.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for CONMED Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCONMED Corporation — frequently asked questions
What is CONMED Corporation's price-to-earnings ratio?
CONMED Corporation (CNMD) reported price-to-earnings ratio of 26.89 for fiscal year 2025, per its SEC filings.
How has CONMED Corporation's price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, CNMD's price-to-earnings ratio declined at roughly 3.2% per year (compound annual rate), from 45.17 to 26.89.
Where does this data come from?
Figures are computed from CONMED Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More CNMD financial history
Full CNMD fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →